RAJANT AND ACUBIS TECHNOLOGIES ANNOUNCE SUCCESSFUL FE1 PEREGRINE AND HAWK DEPLOYMENTS FOR STANWELL’S MEANDU MINE
May 17, 2022 06:00 ET | Rajant Corporation
Malvern, Pennsylvania (USA), May 17, 2022 (GLOBE NEWSWIRE) -- Rajant Corporation, the pioneer of Kinetic Mesh® wireless networks, and Acubis Technologies, a Kinetic Mesh Premier Partner (KMPP) in...
RAJANT ANNOUNCES NEW LTE BREADCRUMB PLUS PERSONNEL AND ASSET TRACKING “MESHTRACER” SOFTWARE AT MINEXPO
September 13, 2021 08:00 ET | Rajant Corporation
Malvern, Pennsylvania (USA), Sept. 13, 2021 (GLOBE NEWSWIRE) -- Rajant Corporation, the provider of Kinetic Mesh® wireless networks, announces two new products at MINExpo. The latest enhancement...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
February 12, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif. and BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Oncologie, Inc. today announced that the companies have entered into an...
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
January 05, 2018 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company working to improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
January 02, 2018 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer
December 26, 2017 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 26, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments
December 11, 2017 16:05 ET | Peregrine Pharmaceuticals Inc.
-- Avid Bioservices Records Revenues of $12.8 Million in the Second Quarter of FY2018 --             -- Transition to a Dedicated CDMO Business Nearing Completion -- TUSTIN, Calif., Dec. 11, 2017 ...
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement
November 28, 2017 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif. and CHICAGO, Ill., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) (“Peregrine”) and Ronin Trading, LLC and SW Investment Management...
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
October 24, 2017 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
October 19, 2017 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...